Skip to main content
Skip to main content
IWINF logo

Irwin Naturals Inc. (IWINF)

$0.50 +$0.17 (+51.52%) |CouncilHOLD · 43 · C
Bottom line: HOLD — our Council read (43/100) and AI Score (43/100) broadly agree.
MCap: $1.68M| Vol: 100|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Irwin Naturals Inc. (IWINF) trades at $0.50 with AI Score 43/100 (Grade C). Irwin Naturals Inc. distributes CBD products internationally, operating through online channels and approximately 100,000 stores. Market cap: $1.68M, Sector: Healthcare.

Price live · AI analysis from Mar 18, 2026
Irwin Naturals Inc. distributes CBD products internationally, operating through online channels and approximately 100,000 stores. The company focuses on herbal supplements and wellness products.

Analyst Coverage for IWINF: IWINF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IWINF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 43/100 · C

IWINF: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Irwin Naturals Inc. (IWINF) Healthcare & Pipeline Overview

CEOKlee Irwin
HeadquartersLos Angeles, US
IPO Year2021

Irwin Naturals Inc. is a herbal supplement company focused on the distribution of CBD products across the United States and internationally. Operating through a network of approximately 100,000 stores and online channels, the company targets the growing market for natural health and wellness solutions, facing competition in the evolving CBD landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 18, 2026

What Is the Investment Thesis for IWINF?

Irwin Naturals Inc. presents a focused investment opportunity within the expanding CBD and herbal supplement market. With a wide distribution network of approximately 100,000 stores and an online presence, the company has established market access. Key value drivers include the growth of the CBD market, expansion of product lines, and strategic partnerships to enhance distribution. A potential catalyst is the evolving regulatory landscape for CBD products, which could provide both opportunities and challenges. The company's negative P/E ratio of -0.18 and negative profit margin of -4.5% indicate financial challenges that require careful consideration. Investors should monitor the company's ability to improve profitability and manage regulatory risks.

Based on FMP financials and quantitative analysis

IWINF Key Highlights

  • Operates in the herbal supplement and CBD product market.
  • Distributes products through approximately 100,000 stores and online channels.
  • Gross Margin of 45.5% indicates potential for profitability with effective cost management.
  • Negative P/E ratio of -0.18 reflects current earnings challenges.
  • Beta of -0.10 suggests low volatility compared to the market.

Who Are IWINF's Competitors?

IWINF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company $4.88 -5.97% $1.80B 68
MEDS TRxADE HEALTH, Inc. $7.59 +4.55% $13.28M 63
ONC BeOne Medicines Ltd. $309.46 +3.97% $33.07B 61
NEUP Neuphoria Therapeutics Inc. $3.44 +1.78% $18.59M 60
YI 111, Inc. $4.13 -0.12% $36.04M 44
ALBHF Alibaba Health Information Technology Limited $0.42 +2.44% $6.77B 45
WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company $11.98 +0.50% $10.37B 45
IPXL Impax Laboratories, Inc. $18.30 +0.55% 46

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IWINF's Key Strengths?

  • Wide distribution network of approximately 100,000 stores.
  • Established brand recognition in the herbal supplement market.
  • Online sales channel for direct-to-consumer reach.
  • Focus on the growing CBD market.

What Are IWINF's Weaknesses?

  • Negative P/E ratio and profit margin indicate financial challenges.
  • Dependence on third-party retailers for distribution.
  • Limited information available on R&D and product innovation.
  • Exposure to evolving and uncertain regulatory landscape.

What Could Drive IWINF Stock Higher?

  • Potential changes in CBD regulations could create new market opportunities.
  • Expansion of product lines to meet evolving consumer demand.
  • Strategic partnerships to enhance distribution and market reach.

What Are the Key Risks for IWINF?

  • Financial-distress signal — its Altman Z-Score of -0.16 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-21.2%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Intense competition from other CBD and supplement companies.
  • Fluctuations in consumer demand and preferences.
  • Regulatory uncertainty and potential restrictions on CBD products.
  • Supply chain disruptions and cost increases.
  • Negative P/E ratio and profit margin indicate financial challenges.

What Are the Growth Opportunities for IWINF?

  • Expansion of Product Lines: Irwin Naturals can capitalize on the growing demand for diverse CBD and herbal supplement products by expanding its product lines to include new formulations, delivery methods, and targeted health solutions. The global herbal medicine market is projected to reach $129.3 billion by 2028, presenting a significant opportunity for Irwin Naturals to increase its market share through innovative product development. Timeline: Ongoing.
  • Strategic Partnerships: Forming strategic partnerships with established retailers, distributors, and healthcare providers can significantly expand Irwin Naturals' market reach and brand recognition. Collaborations with major retail chains or online marketplaces can provide access to a broader customer base and enhance distribution efficiency. The timeline for establishing such partnerships is estimated at 6-12 months.
  • International Expansion: Expanding into new international markets presents a significant growth opportunity for Irwin Naturals, particularly in regions with increasing acceptance of CBD and herbal supplements. Identifying and targeting specific countries with favorable regulatory environments and consumer demand can drive revenue growth and diversify the company's market presence. Timeline: 12-24 months.
  • Online Channel Optimization: Enhancing the company's online presence and e-commerce capabilities can drive direct-to-consumer sales and improve customer engagement. Investing in user-friendly website design, targeted online marketing campaigns, and efficient order fulfillment processes can increase online sales and brand loyalty. The timeline for optimizing online channels is estimated at 3-6 months.
  • Regulatory Tailwinds: The evolving regulatory landscape for CBD products presents both opportunities and challenges for Irwin Naturals. As regulations become more standardized and favorable, the company can benefit from increased market legitimacy and consumer confidence. Monitoring and adapting to regulatory changes will be crucial for capitalizing on this growth opportunity. Timeline: Ongoing.

What Opportunities Does IWINF Have?

  • Expansion into new international markets.
  • Development of new and innovative CBD and herbal supplement products.
  • Strategic partnerships with major retailers and healthcare providers.
  • Increased consumer awareness and acceptance of CBD products.

What Threats Does IWINF Face?

  • Intense competition from other CBD and supplement companies.
  • Changing regulatory environment and potential restrictions on CBD products.
  • Fluctuations in consumer demand and preferences.
  • Potential supply chain disruptions and cost increases.

What Are IWINF's Competitive Advantages?

  • Extensive Distribution Network: Access to approximately 100,000 stores provides a wide reach.
  • Established Brand: Irwin Naturals has built a recognized brand in the supplement market.
  • Online Presence: The company's online platform allows for direct-to-consumer sales.

What Does IWINF Do?

Irwin Naturals Inc., formerly known as Datinvest International Ltd., is a Los Angeles-based company operating within the herbal supplement and CBD product market. The company distributes its products through a wide network of approximately 100,000 stores and online platforms, reaching both domestic and international consumers. Irwin Naturals focuses on providing a range of herbal supplements and CBD products, catering to the increasing consumer demand for natural health and wellness solutions. Founded with a vision to provide accessible and effective herbal supplements, Irwin Naturals has evolved to capitalize on the burgeoning CBD market. The company's strategic focus on distribution through established retail channels and online platforms allows it to reach a broad customer base. Irwin Naturals continues to adapt its product offerings to meet changing consumer preferences and regulatory landscapes within the CBD and supplement industries. The company's commitment to quality and accessibility has established it as a notable player in the competitive market.

What Products and Services Does IWINF Offer?

  • Distributes CBD products in the United States and internationally.
  • Offers herbal supplements.
  • Sells products through approximately 100,000 stores.
  • Provides products online.
  • Focuses on natural health and wellness solutions.
  • Adapts product offerings to meet changing consumer preferences.

How Does IWINF Make Money?

  • Sells herbal supplements and CBD products through retail partnerships.
  • Generates revenue through online sales.
  • Focuses on distribution to a broad customer base.

What Industry Does IWINF Operate In?

Irwin Naturals Inc. operates in the rapidly evolving herbal supplement and CBD market. The industry is characterized by increasing consumer interest in natural health solutions and growing acceptance of CBD products. The competitive landscape includes companies like ACNNF (Accannabis), CANB (Can B Corp), CBDNF (CBD of Denver Inc), ETRGF (EuroTech Holdings Co), and GABLF (Global Asset Backed Corp), each vying for market share. The market is subject to changing regulations and consumer preferences, requiring companies to adapt their strategies to remain competitive. The global CBD market is projected to continue its growth trajectory, presenting opportunities for companies like Irwin Naturals to expand their market presence.

Who Are IWINF's Key Customers?

  • Consumers seeking natural health and wellness solutions.
  • Individuals interested in CBD products.
  • Customers purchasing through retail stores.
  • Online shoppers looking for herbal supplements.
AI Confidence: 79% Updated: Mar 18, 2026

ROE -21%Key Financial Metrics

Return on equity for Irwin Naturals Inc. stands at -21.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -5.1%, showing how much profit it generates from its asset base. A current ratio of 1.24 indicates the company holds enough short-term assets to cover its near-term obligations.

How Irwin Naturals Inc. Is Valued

Irwin Naturals Inc. carries a market capitalization of $1.68M, placing it in the micro-cap category. Relative to its peer group, IWINF's quantitative score of 43/100 is below the peer average of 59/100.

F-Score 2/9Financial Health

Irwin Naturals Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.16 places it in the distress zone, a signal of elevated financial risk.

IWINF Financials

Fundamental Snapshot

Return on Equity (TTM)
-21.2%
Current Ratio
1.2
EV/EBITDA (TTM)
14.5

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Wide distribution network of approximately 100,000 stores.
  • Established brand recognition in the herbal supplement market.
  • Online sales channel for direct-to-consumer reach.
  • Focus on the growing CBD market.

Bear Case

  • Negative P/E ratio and profit margin indicate financial challenges.
  • Dependence on third-party retailers for distribution.
  • Limited information available on R&D and product innovation.
  • Exposure to evolving and uncertain regulatory landscape.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

IWINF Latest News

No recent news available for IWINF.

IWINF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IWINF.

Price Targets

Wall Street price target analysis for IWINF.

IWINF MoonshotScore

43/100

What does this score mean?

The MoonshotScore rates IWINF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Klee Irwin

CEO

Klee Irwin is the Chief Executive Officer of Irwin Naturals Inc. He has been involved with the company for several years, guiding its strategic direction and growth initiatives. Irwin's background includes experience in business development, marketing, and product innovation within the health and wellness sector. He is focused on expanding the company's market presence and enhancing its product offerings to meet evolving consumer needs.

Track Record: Under Klee Irwin's leadership, Irwin Naturals Inc. has expanded its distribution network and increased its focus on the CBD market. He has overseen the development of new product lines and the implementation of strategic marketing campaigns to drive sales growth. Irwin has also navigated the company through regulatory challenges and evolving market dynamics.

IWINF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that the company may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk. This tier is often associated with speculative investments and requires careful due diligence.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity for IWINF on the OTC market is likely limited, given its classification in the OTC Other tier. This typically translates to lower trading volumes and wider bid-ask spreads, making it potentially difficult for investors to buy or sell shares quickly without significantly impacting the price. Investors should be prepared for potential price volatility and execution challenges due to the limited liquidity.
OTC Risk Factors:
  • Limited Disclosure: Lack of financial transparency due to the company's disclosure status.
  • Low Liquidity: Potential difficulty in buying or selling shares due to low trading volume.
  • Price Volatility: Higher price volatility compared to stocks listed on major exchanges.
  • Regulatory Uncertainty: Exposure to regulatory risks associated with the OTC market and the CBD industry.
  • Speculative Investment: Higher risk due to the speculative nature of OTC Other stocks.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Assess the company's management team and their track record.
  • Evaluate the company's business model and competitive positioning.
  • Review the company's legal and regulatory compliance.
  • Analyze the company's capital structure and debt levels.
  • Monitor news and press releases for any material developments.
  • Consult with a financial advisor to assess the risks and potential rewards.
Legitimacy Signals:
  • Established Distribution Network: The company's access to approximately 100,000 stores suggests a degree of operational scale.
  • Online Presence: The company's online platform allows for direct-to-consumer sales.
  • Focus on Growing Market: The company's focus on the CBD market aligns with a growing industry trend.

Irwin Naturals Inc. Healthcare Stock: Key Questions Answered

What does Irwin Naturals Inc. do?

Irwin Naturals Inc. is a herbal supplement company that distributes CBD products in the United States and internationally. It offers a range of herbal supplements and CBD products through approximately 100,000 stores and online channels. The company focuses on providing natural health and wellness solutions to consumers, catering to the growing demand for alternative and complementary medicine. Irwin Naturals aims to provide accessible and effective products in the competitive herbal supplement and CBD market.

What are the main risks for IWINF?

The main risks for Irwin Naturals Inc. include intense competition from other CBD and supplement companies, regulatory uncertainty surrounding CBD products, fluctuations in consumer demand, and potential supply chain disruptions. The company's negative P/E ratio and profit margin also indicate financial challenges that could impact its ability to grow and compete effectively. Investors should carefully consider these risks and conduct thorough due diligence before investing in IWINF.

How does Irwin Naturals Inc. navigate regulatory approval processes?

As a distributor of herbal supplements and CBD products, Irwin Naturals Inc. must navigate a complex regulatory landscape. The company ensures compliance with FDA regulations regarding the manufacturing, labeling, and marketing of its products. While CBD products face evolving regulations, Irwin Naturals monitors and adapts to these changes to maintain compliance. The company's strategy includes adhering to quality control standards, providing accurate product information, and engaging with regulatory agencies to stay informed about new requirements. This proactive approach helps Irwin Naturals mitigate regulatory risks and maintain consumer trust.

What is Irwin Naturals Inc.'s competitive strategy in the CBD market?

Irwin Naturals Inc.'s competitive strategy in the CBD market focuses on leveraging its extensive distribution network, established brand recognition, and online presence. The company differentiates itself by offering a diverse range of herbal supplements and CBD products, catering to various consumer needs. Irwin Naturals also emphasizes quality and accessibility, aiming to provide effective products at competitive prices. By expanding its product lines, forming strategic partnerships, and optimizing its online channels, Irwin Naturals seeks to increase its market share and strengthen its competitive position in the rapidly growing CBD market.

What are the key factors to evaluate for IWINF?

Irwin Naturals Inc. (IWINF) holds an AI score of 43/100 (low). Not financial advice.

How frequently does IWINF data refresh on this page?

IWINF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven IWINF's recent stock price performance?

Irwin Naturals Inc. (IWINF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Wide distribution network of approximately 100,000 stores. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider IWINF overvalued or undervalued right now?

Valuing Irwin Naturals Inc. (IWINF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • OTC data may be less reliable than exchange-listed data.
  • AI analysis pending for IWINF.
Data Sources

Popular Stocks